Z16.35
Resistance to multiple antimicrobial drugs
Clinical Classification Guidelines
Excludes Type 1
- Resistance to multiple antibiotics only (Z16.24)
Medical Intelligence & Overview
Resistance to multiple antimicrobial drugs, classified under ICD-10 code Z16.35, occurs when bacteria or other microorganisms develop the ability to withstand the effects of various antibiotics or antimicrobial agents. This resistance complicates treatment options and can lead to persistent infections, increased healthcare costs, and higher risks of severe health outcomes. Recognizing the factors that cause antimicrobial resistance and understanding its impact are essential steps toward effective management and prevention.
Causes & Symptoms
Clinical Causes: Overuse or misuse of antibiotics in human medicine, such as not completing prescribed courses or using antibiotics unnecessarily. Use of antibiotics in agriculture and livestock, which can promote resistant bacteria that transfer to humans. Poor infection control practices in healthcare settings, facilitating the spread of resistant microorganisms. Environmental factors, including contamination of water and soil with antibiotic-resistant bacteria. Lack of new antibiotics development, leading to limited options for resistant infections.
Key Symptoms: Persistent or recurrent infections that do not respond to standard treatments. Worsening symptoms despite completing prescribed medication courses. Infections that require higher doses or alternative medications to achieve cure. Signs of severe infections, such as fever, chills, fatigue, and localized pain or swelling. Potential spread of resistant bacteria to other parts of the body or to other individuals.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of antimicrobial resistance typically involves laboratory testing of microorganisms isolated from infected sites. Techniques include culture and sensitivity testing to determine which drugs the bacteria are resistant or sensitive to. Healthcare providers may also assess the patient's medical history, previous antibiotic use, and exposure risks to understand the development of resistance. Molecular methods, such as PCR, may be used to identify specific resistance genes.
Treatment Protocols: Utilizing antibiotics that the microorganism has not previously been exposed to or that it remains susceptible to, based on sensitivity testing. Developing novel antibiotics or adjunct therapies to overcome resistance mechanisms. Implementing infection control measures to prevent the spread of resistant bacteria in healthcare settings. Promoting antimicrobial stewardship programs aimed at optimizing the use of antibiotics to reduce resistance development. Supporting research and development efforts to discover new antimicrobial agents.
Clinical Advice & FAQs
Billing Guidance
Is Z16.35 a billable ICD-10 code?
Yes, Z16.35 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z16.35?
Clinical documentation must specify the nature of Resistance to multiple antimicrobial drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference